These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1995 related items for PubMed ID: 27189912

  • 1. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
    Gracie DJ, Williams CJ, Sood R, Mumtaz S, Bholah MH, Hamlin PJ, Ford AC.
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
    [Abstract] [Full Text] [Related]

  • 2. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N, Cummins E, Royle P, Kandala NB, Shyangdan D, Arasaradnam R, Clar C, Johnston R.
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [Abstract] [Full Text] [Related]

  • 3. Predictors of irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease.
    Ahmed M, Pu A, Jencks K, Bishu S, Higgins P, Chey WD, Rao K, Lee A.
    Neurogastroenterol Motil; 2024 Jun; 36(6):e14809. PubMed ID: 38651743
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.
    Berrill JW, Green JT, Hood K, Campbell AK.
    Aliment Pharmacol Ther; 2013 Jul; 38(1):44-51. PubMed ID: 23668698
    [Abstract] [Full Text] [Related]

  • 7. The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.
    Hoekman DR, Zeevenhooven J, D'Haens GR, Benninga MA.
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1086-1090. PubMed ID: 28639969
    [Abstract] [Full Text] [Related]

  • 8. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission.
    Jonefjäll B, Strid H, Ohman L, Svedlund J, Bergstedt A, Simren M.
    Neurogastroenterol Motil; 2013 Sep; 25(9):756-e578. PubMed ID: 23731196
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N.
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [Abstract] [Full Text] [Related]

  • 13. Does symptom activity explain psychological differences in patients with irritable bowel syndrome and inflammatory bowel disease? Results from a multi-center cross-sectional study.
    Berens S, Schaefert R, Baumeister D, Gauss A, Eich W, Tesarz J.
    J Psychosom Res; 2019 Nov; 126():109836. PubMed ID: 31627144
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a 'real-world' view.
    McFarlane M, Chambers S, Malik A, Lee B, Sung E, Nwokolo C, Waugh N, Arasaradnam R.
    BMJ Open; 2016 Jun 06; 6(6):e011041. PubMed ID: 27266773
    [Abstract] [Full Text] [Related]

  • 15. Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.
    Lundgren D, Rutegård J, Eklöf V, Palmqvist R, Karling P.
    BMC Gastroenterol; 2016 Nov 24; 16(1):139. PubMed ID: 27881072
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan 24; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.
    Ozer M, Bengi G, Colak R, Cengiz O, Akpinar H.
    Medicine (Baltimore); 2020 May 24; 99(19):e20067. PubMed ID: 32384473
    [Abstract] [Full Text] [Related]

  • 19. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.
    Campbell JP, Zierold C, Rode AM, Blocki FA, Vaughn BP.
    J Clin Gastroenterol; 2021 Mar 01; 55(3):239-243. PubMed ID: 32324678
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 100.